Figure 6.
The potential biomarkers associated with the administration of TXYF. (A) Identified taxonomic features of significant differences across three groups by LEfSe (LDA score ≥ 4 and p-value ≤ 0.05). (B) Identified discriminative species between the TXYF (gttm) and placebo (gtmm) groups by Metastats analysis.
